Dna Twopointo INC.
UEI G9S3SC8T5DM1 · CA · subsidiary of Dna Twopointo INC · SAM.gov record ↗
$150K
FY2025 obligations
1
Contract awards
May 13, 2023
First action
Jul 19, 2026
Latest action
Obligations by agency
- Department Of Health And Human Services$150K
Obligations by NAICS
Monthly obligations
Apr 25
Jul 26
Contracts ending within 18 months (recompete watch)
- 75N93023P00594 ↗$150K
YEARLY LICENSE (MAINTENANCE FEE AND IND FILING FEE) TO USE A MONOCLONAL ANTIBODY PRODUCED VIA ATUM PROPRIETARY CELL LINE TECHNOLOGY
- Ends
- May 12, 2027
- Started
- May 13, 2023
- Agency
- National Institutes Of Health
- NAICS
- 325414
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93023P00594 ↗ | YEARLY LICENSE (MAINTENANCE FEE AND IND FILING FEE) TO USE A MONOCLONAL ANTIBODY PRODUCED VIA ATUM PROPRIETARY CELL LINE TECHNOLOGY | National Institutes Of Health | 325414 | $150K | May 13, 2023 | May 12, 2027 |
Largest awards
- 75N93023P00594 ↗$150K
YEARLY LICENSE (MAINTENANCE FEE AND IND FILING FEE) TO USE A MONOCLONAL ANTIBODY PRODUCED VIA ATUM PROPRIETARY CELL LINE TECHNOLOGY
- Ends
- May 12, 2027
- Started
- May 13, 2023
- Agency
- National Institutes Of Health
- NAICS
- 325414
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93023P00594 ↗ | YEARLY LICENSE (MAINTENANCE FEE AND IND FILING FEE) TO USE A MONOCLONAL ANTIBODY PRODUCED VIA ATUM PROPRIETARY CELL LINE TECHNOLOGY | National Institutes Of Health | 325414 | $150K | May 13, 2023 | May 12, 2027 |